TAPBOOSTTM is a proprietary technology that facilitates increased production of proteins that are often difficult to express or prone to misfolding using bacterial, mammalian, and antibody expression platforms. It works by utilizing a sequence that promotes protein folding and secretion. TAPBOOSTTM has been shown to significantly enhance the yields of various therapeutic proteins including Factor VIII-Fc for hemophilia treatment, IL13Rα2-Fc, and monoclonal antibodies like Humira, Avastin, and DP12. It can increase protein productivity by over 1000% for some targets and holds potential to help address the challenges of producing biologics at commercial scales.